Increased level of tetanus antibody twenty one years after a booster dose of tetanus vaccine.
DOI:
https://doi.org/10.20344/amp.1649Abstract
We report the case of a 37 years old woman who asked for clinical advice about revaccination with tetanus toxoid. An adverse reaction to the last booster dose of vaccine, 21 years before, was recorded by a clinical doctor on the vaccination card. It was decided to evaluate serum antibody levels against tetanus and other diseases included in the Portuguese Vaccination Programme. The level of serum tetanus antitoxin (IgG) observed (6.4 IU/ml) corresponds to high protection against the disease and furthermore it is considered as a contraindication to vaccination due to the increased risk of adverse reactions to revaccination. The woman was susceptible to pertussis and diphtheria, and immune to measles, mumps and rubella. It was recommended that the woman should not receive tetanus toxoid and a new serological evaluation would be done 10 years after, in order to support the decision about revaccination.Downloads
Downloads
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
